PubMed

Is C-reactive protein specific for vascular disease in women?

Rifai N, Buring JE, Lee IM, Manson JE, Ridker PM.

Ann Intern Med. 2002 Apr 2;136(7):529-33.PMID: 11926788 [PubMed - indexed for MEDLINE]Related articlesFree article

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.

Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM.

JAMA. 2002 Aug 28;288(8):980-7.PMID: 12190368 [PubMed - indexed for MEDLINE]Related articlesFree article

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM.

JAMA. 2001 Jul 18;286(3):327-34.PMID: 11466099 [PubMed - indexed for MEDLINE]Related articlesFree article

A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.

Blake GJ, Dada N, Fox JC, Manson JE, Ridker PM.

J Am Coll Cardiol. 2001 Nov 1;38(5):1302-6.PMID: 11691499 [PubMed - indexed for MEDLINE]Related articles

C-reactive protein levels are not associated with increased risk for colorectal cancer in women.

Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM.

Ann Intern Med. 2005 Mar 15;142(6):425-32.PMID: 15767620 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.

Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH.

Circulation. 1998 Aug 25;98(8):731-3.PMID: 9727541 [PubMed - indexed for MEDLINE]Related articlesFree article

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE.

JAMA. 2005 Jul 20;294(3):326-33.PMID: 16030277 [PubMed - indexed for MEDLINE]Related articlesFree article

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.PMID: 15811980 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.

Seddon JM, George S, Rosner B, Rifai N.

Arch Ophthalmol. 2005 Jun;123(6):774-82.PMID: 15955978 [PubMed - indexed for MEDLINE]Related articles

The relation of C-reactive protein levels to total and cardiovascular mortality in older U.S. women.

Tice JA, Browner W, Tracy RP, Cummings SR.

Am J Med. 2003 Feb 15;114(3):199-205.PMID: 12637134 [PubMed - indexed for MEDLINE]Related articles

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH.

Arterioscler Thromb Vasc Biol. 1997 Jun;17(6):1121-7.PMID: 9194763 [PubMed - indexed for MEDLINE]Related articlesFree article

C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.

Wilson PW, Nam BH, Pencina M, D'Agostino RB Sr, Benjamin EJ, O'Donnell CJ.

Arch Intern Med. 2005 Nov 28;165(21):2473-8.PMID: 16314543 [PubMed - indexed for MEDLINE]Related articlesFree article

Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study.

Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH Jr, Howard BV, Assaf AR, Prentice R; Women's Health Initiative Research Group.

Arch Intern Med. 2005 Mar 14;165(5):500-8.PMID: 15767524 [PubMed - indexed for MEDLINE]Related articlesFree article

Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.

Mora S, Rifai N, Buring JE, Ridker PM.

Circulation. 2006 Aug 1;114(5):381-7. Epub 2006 Jul 24.PMID: 16864722 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C-reactive protein.

Bansal S, Ridker PM.

Am J Cardiol. 2007 Jun 1;99(11):1500-3. Epub 2007 Apr 12.PMID: 17531569 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

Cook NR, Buring JE, Ridker PM.

Ann Intern Med. 2006 Jul 4;145(1):21-9.PMID: 16818925 [PubMed - indexed for MEDLINE]Related articlesFree article

Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.

Onat A, Can G, Hergenç G.

Metabolism. 2008 Feb;57(2):207-14.PMID: 18191050 [PubMed - indexed for MEDLINE]Related articles

Value of C-reactive protein levels and IL-6 in predicting events levels in women at increased cardiovascular risk.

Vitale C, Gebara O, Mercuro G, Wajngarten M, Silvestri A, Rossini P, Ramires JA, Fini M, Rosano GM.

Maturitas. 2005 Apr 11;50(4):239-46.PMID: 15780522 [PubMed - indexed for MEDLINE]Related articles

Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.

Joffe HV, Ridker PM, Manson JE, Cook NR, Buring JE, Rexrode KM.

Ann Epidemiol. 2006 Feb;16(2):105-12. Epub 2005 Oct 10.PMID: 16216530 [PubMed - indexed for MEDLINE]Related articles

C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.

Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V.

Thromb Haemost. 2006 Mar;95(3):511-8.PMID: 16525580 [PubMed - indexed for MEDLINE]Related articles